Enterprise Deployment Through PulseRider To Treat Anterior Communicating Artery Aneurysm Recurrence
Iacopo Valente1, Nicola Limbucci2, Sergio Nappini2
1Interventional Neurovascular Unit, Careggi University Hospital, Firenze, Italy; Institute of Radiological Sciences, Catholic University of Sacred Heart, Agostino Gemelli University Polyclinic Foundation, Rome, Italy.
Background:
PulseRider (Pulsar Vascular, Los Gatos, California, USA) is a new endovascular device designed to treat wide-neck bifurcation intracranial aneurysms. Deployment of a stent through a PulseRider to treat an aneurysm's recurrence has never been described before.
Case Description:
We report the case of a 55-year-old man who underwent coiling of an 8-mm anterior communicating artery aneurysm with assistance of a PulseRider neck reconstruction device. The 6-month digital subtraction angiography control showed aneurysm recurrence, so we deployed an Enterprise 2 closed-cell stent (Codman, Miami Lakes, Florida, USA) in the A1-A2 segment passing across the previously implanted PulseRider. Enterprise correctly expanded and allowed for adequate coiling of the aneurysm.
Conclusion:
An Enterprise stent can be safely opened through a PulseRider in order to treat aneurysm recurrence.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Aneurysm IV: Nursing Management
Mitral Stenosis III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...


